galieve peppermint 250+133,5+80 mg tyggetabletter
reckitt benckiser healthcare (scandinavia) a/s - calciumcarbonat, natriumalginat, natriumhydrogencarbonat - tyggetabletter - 250+133,5+80 mg
risedronatnatrium "teva" 35 mg filmovertrukne tabletter
teva b.v. - risedronatnatrium - filmovertrukne tabletter - 35 mg
voltaren 1 mg/ml øjendråber, opløsning
2care4 aps - diclofenacnatrium - øjendråber, opløsning - 1 mg/ml
voltaren ophtha 1 mg/ml øjendråber, enkeltdosisbeholder
glaxosmithkline consumer healthcare aps - diclofenacnatrium - øjendråber, enkeltdosisbeholder - 1 mg/ml
voltaren ophtha 1 mg/ml øjendråber, opløsning
glaxosmithkline consumer healthcare aps - diclofenacnatrium - øjendråber, opløsning - 1 mg/ml
oxlumo
alnylam netherlands b.v. - lumasiran sodium - hyperoxaluria, primary - andre alimentary tract and metabolism produkter, - treatment of primary hyperoxaluria type 1 (ph1) in all age groups.
vocabria
viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv infektioner - antivirale midler til systemisk anvendelse - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sunlenca
gilead sciences ireland unlimited company - lenacapavir sodium - hiv infektioner - antivirale midler til systemisk anvendelse - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 og 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 og 5.